03:29 AM EDT, 05/18/2026 (MT Newswires) -- AstraZeneca (AZN) said Monday the US Food and Drug Administration has approved its drug Baxfendy for use with other blood pressure drugs to treat adults whose hypertension is not adequately controlled.

The company said the approval was based on a late-stage trial showing the drug reduced seated systolic blood pressure at 2 mg and 1 mg doses in patients with uncontrolled or resistant hypertension taking two or more medications.

Ämnen i artikeln

AstraZeneca

Senast

1 711,00

1 dag %

0,26%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån